Skip to content
StockMarketAgent
Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

KOSDAQ/298380 stock hub

KOSDAQ/298380 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/298380is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
7.3T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/298380
In the news

Latest news · KOSDAQ/298380

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-23.4
P25 -17.1P50 0.7P75 8.5
ROIC-11.9
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/298380 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
169
Groups with data
11
Currency
KRW
Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
102
Enterprise value
KRW 7.2T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Medical - Pharmaceuticals
Isin
KR7298380007
Last refreshed
2026-05-10
Market cap
KRW 7.3T
Price
KRW 130,100
Price currency
KRW
Rev Per Employee
777,939,686.27x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/298380
Website
https://www.ablbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-0.52%
EV Earnings
-191.14x
EV/FCF
-117.85x
EV/Sales
91.07x
FCF yield
-0.84%
P/B ratio
46.48x
P/S ratio
91.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-50.9%
EBITDA Margin
-46.55%
Gross margin
99.85%
Gross Profit
KRW 79.2B
Gross Profit Growth
137.63%
Gross Profit Growth3 Y
5.63%
Net Income
KRW -37.8B
Net Income Growth Years
1%
Pretax Margin
-47.73%
Profit Margin
-47.65%
Profit Per Employee
KRW -370.7M
ROA
-9.84
ROCE
-25.65
ROE
-23.38
ROIC
-11.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
109.27%
Cagr3y
80.13%
Cagr5y
43.68%
EPS Growth Years
1
Revenue Growth
137.55x
Revenue Growth Years
1x
Revenue Growth3 Y
5.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
KRW 0.31
Assets
KRW 280.9B
Cash
KRW 114.9B
Current Assets
KRW 176.1B
Current Liabilities
KRW 123.5B
Debt
KRW 55.3B
Debt Equity
KRW 0.35
Debt FCF
KRW -0.9
Equity
KRW 156.7B
Interest Coverage
-40.67
Liabilities
KRW 124.2B
Long Term Assets
KRW 104.9B
Long Term Liabilities
KRW 739.1M
Net Cash
KRW 59.6B
Net Cash By Market Cap
KRW 0.82
Net Cash Growth
-39.07%
Net Debt Equity
KRW -0.38
Tangible Book Value
KRW 151.9B
Tangible Book Value Per Share
KRW 2,755
WACC
6.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.43
Net Working Capital
KRW -7.3B
Quick ratio
1.41
Working Capital
KRW 52.6B
Working Capital Turnover
KRW 1.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-7.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
109.16%
200-day SMA
144,184.5
3Y total return
484.72%
50-day SMA
166,574
50-day SMA vs 200-day SMA
50over200
5Y total return
512.24%
All Time High
257,500
All Time High Change
-49.48%
All Time High Date
2026-01-28
All Time Low
12,250
All Time Low Change
962.04%
All Time Low Date
2020-03-19
ATR
9,877.8
Beta
0.33
Beta1y
0.51
Beta2y
0.21
Ch YTD
-34.95
High
131,500
High52
257,500
High52 Date
2026-01-29
High52ch
-49.48%
Low
127,600
Low52
57,700
Low52 Date
2025-05-14
Low52ch
125.48%
Ma50ch
-21.9%
Price vs 200-day SMA
-9.77%
RSI
36.07
RSI Monthly
59.1
RSI Weekly
36.11
Sharpe ratio
1.09x
Sortino ratio
1.94
Total Return
-7.25%
Tr YTD
-34.95
Tr1m
-15.41%
Tr1w
-1.81%
Tr3m
-26.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -40.4B
Operating margin
-50.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
41,572,267%
Net Borrowing
11,324,062,860
Shares Insiders
25.75%
Shares Institutions
14.41%
Shares Out
55,987,463
Shares Qo Q
2.38%
Shares Yo Y
7.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
KRW -66.8B
Average Volume
585,922.6x
Bv Per Share
2,806.7
CAPEX
KRW -20.1B
Ch1m
-15.41
Ch1w
-1.81
Ch1y
109.2
Ch3m
-26.75
Ch3y
484.7
Ch5y
512.2
Ch6m
28.43
Change
2.93%
Change From Open
1.48
Close
126,400
Days Gap
1.42
Depreciation Amortization
3,449,155,000
Dollar Volume
60,235,909,700
Earnings Date
2026-05-13
EBIT
KRW -40.4B
EBITDA
KRW -36.9B
EPS
KRW -734
F Score
2
FCF
KRW -61.3B
FCF EV Yield
-0.85x
FCF Per Share
KRW -1,095
Financing CF
32,519,310,000
Fiscal Year End
December
Founded
2,016
Investing CF
62,113,159,400
Is Primary Listing
1
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Ma150
163,468
Ma150ch
-20.41%
Ma20
149,805
Ma20ch
-13.15%
Net CF
55,692,962,390
Next Earnings Date
2026-05-13
Open
128,200
Position In Range
64.1
Ppne
101,141,547,930
Price Date
2026-05-08
Ptbv Ratio
47.97
Relative Volume
0.79x
Revenue
79,349,848,000x
SBC By Revenue
6.85x
Share Based Comp
5,436,944,000
Tr6m
28.43%
Volume
462,997
Z Score
19
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/298380 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/298380 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+109.2%
S&P 500 1Y: n/a
3Y total return
+484.7%
S&P 500 3Y: n/a
5Y total return
+512.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/298380?

Insider, institutional, and short-interest positioning.

Institutional ownership
+14.4%
Share of float held by funds and institutions
Insider ownership
+25.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+7.2%
Negative means the company is buying back shares.
Technical

KOSDAQ/298380 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.1
Neutral momentum band
Price vs 200-day MA
-9.8%
50/200-day relationship not available
Beta (5Y)
0.33
Less volatile than the market
Sharpe ratio
1.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/298380

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/298380 stock rating?

kosdaq/298380 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/298380 analysis?

The full report lives at /stocks/kosdaq/298380/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/298380?

The latest report frames kosdaq/298380 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/298380 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.